Ultrasonography Guided Brain Lesions Resection:

September 24, 2020 updated by: Sarah Ahmed Saad, Assiut University

Ultrasonography Guided Brain Lesions Resection: a Tool for a Real Time Intraoperative Neuronavigation

  1. Evaluate the clinical value of intraoperative ultrasonography as a real-time guidance
  2. Combination of data of MRI Tractography and intra operative ultrasonography will be useful in good localization of lesions or not .
  3. Maximal safe resection .

Study Overview

Detailed Description

Accurate pre and intraoperative localization of Brain lesions is a challenge in neurosurgery specially deep intra cerebral lesions. Stereotaxy and neuronavigator played a major role in preoperative and intraoperative evaluation of exact location of intra cerebral lesions, the main drawbacks of using steriotaxy and neuronavigator that they are time consuming, complicated and expensive.(1) Nowadays we use MRI Tractography as preoperative imaging to localize lesions and there relation to neural tracts specially in eloquent brain areas, and also intraoperative ultrasonography Which act as a real-time, unexpansive and relatively simple tool for intraoperative visualization of the lesion's location, size, extent and its relationship with the surrounding tissue, also it can reveal the lesion's blood supply, it can measure the rate and direction of arterial blood flow.(2,3,4) Intraoperative ultrasonic imaging was first applied as a real-time navigation system in neurosurgery in 1980. (5) In this research we will combine the use of preoperative MRI tractography with intra operative ultrasonography in accurate localization of brain lesions and its relation with important tracts and if this combination will be beneficial and add to the safety of excision of lesions or not.

Study Type

Observational

Enrollment (Anticipated)

1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 70 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients diagnosed to have brain lesion, selected based on the inclusion and exclusion criteria

Description

Inclusion Criteria:

  • Patients who are diagnosed to have Intracranial lesions Patients with recurrent lesions

Exclusion Criteria:

  • Patients who are unfit for surgery Patients who have multifocal lesions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Extent of resection of the lesion
Time Frame: 48 hours
Extent of resection of the lesion evaluated by comparing pre operative and post operative MRI
48 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
post operative complication
Time Frame: one month
post operative complication evaluated by full neurological examination
one month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Radwan nouby mahmoud, prof, assuit nuiversity hospital neurosurgery department
  • Study Director: wael mohamed ali, prof, assuit nuiversity hospital neurosurgery department
  • Study Director: mohamed aly ragaee, prof, assuit nuiversity hospital neurosurgery department

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 25, 2020

Primary Completion (Anticipated)

July 25, 2021

Study Completion (Anticipated)

December 30, 2021

Study Registration Dates

First Submitted

September 24, 2020

First Submitted That Met QC Criteria

September 24, 2020

First Posted (Actual)

September 30, 2020

Study Record Updates

Last Update Posted (Actual)

September 30, 2020

Last Update Submitted That Met QC Criteria

September 24, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • intra operative ultrasound

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patients Who Are Diagnosed to Have Intracranial Lesions

Clinical Trials on use of intraoperative ultrasound

Subscribe